SBH
Sally Beauty Holdings, Inc. NYSE Listed Nov 17, 2006$13.87
Mkt Cap $1.4B
52w Low $8.12
58.6% of range
52w High $17.92
50d MA $14.37
200d MA $14.57
P/E (TTM)
7.2x
EV/EBITDA
7.1x
P/B
1.8x
Debt/Equity
2.0x
ROE
21.9%
P/FCF
9.5x
RSI (14)
—
ATR (14)
—
Beta
1.12
50d MA
$14.37
200d MA
$14.57
Avg Volume
1.5M
Sally Beauty Holdings, Inc. operates as a specialty retailer and distributor of professional beauty supplies. The company operates through two segments, Sally Beauty Supply and Beauty Systems Group. The Sally Beauty Supply segment offers beauty products, including hair color and care products, skin and nail care products, styling tools, and other beauty products for retail customers, salons, and salon professionals. This segment also provides products under third-party brands, such as Wella, Clairol, OPI, Conair, and L'Oreal, as well as exclusive-label brand merchandise. The Beauty Systems Group segment offers professional beauty products, such as hair color and care products, skin and nail care products, styling tools, and other beauty items directly to salons and salon professionals through its professional-only stores, e-commerce platforms, and sales force, as well as through franchised stores under the Armstrong McCall store name. This segment also sells products under third-party brands, such as Paul Mitchell, Wella, Matrix, Schwarzkopf, Kenra, Goldwell, Joico, and Olaplex. As of September 30, 2021, the company operated 4,777 stores, including 134 franchised units in the United States, Puerto Rico, Canada, Mexico, Chile, Peru, the United Kingdom, Ireland, Belgium, France, the Netherlands, Spain, and Germany. It also distributes its products through full-service/exclusive distributors, open-line distributors, direct sales, and mega-salon stores. Sally Beauty Holdings, Inc. was founded in 1964 and is headquartered in Denton, Texas.
3001 Colorado Boulevard · Denton, TX 76210 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 9, 2026 | AMC | 0.47 | 0.48 | +2.1% | 17.00 | +0.7% | -8.2% | -2.4% | +0.1% | +7.2% | -3.7% | — |
| Nov 13, 2025 | AMC | 0.48 | 0.55 | +15.1% | 14.45 | -2.1% | -1.9% | +0.4% | +3.0% | -4.4% | +1.0% | — |
| Aug 5, 2025 | AMC | 0.42 | 0.51 | +21.4% | 11.66 | +0.5% | +3.3% | -2.5% | -0.5% | +1.5% | +6.1% | — |
| May 12, 2025 | AMC | 0.39 | 0.42 | +7.7% | 9.98 | -0.6% | -6.2% | -1.2% | -1.7% | +0.9% | -1.1% | — |
| Feb 13, 2025 | AMC | 0.43 | 0.43 | +0.0% | 9.59 | -0.9% | -3.1% | +0.8% | +1.3% | -1.7% | -4.1% | — |
| Nov 14, 2024 | AMC | 0.47 | 0.50 | +6.4% | 13.78 | +3.0% | -2.7% | -0.5% | -1.9% | +0.4% | -1.2% | — |
| Aug 8, 2024 | AMC | 0.40 | 0.45 | +12.5% | 10.30 | -0.1% | -1.2% | +4.3% | +5.6% | +1.2% | +11.5% | — |
| May 9, 2024 | AMC | 0.40 | 0.35 | -12.5% | 10.34 | -0.2% | +3.1% | +5.4% | +1.6% | -4.3% | +3.2% | — |
| Feb 1, 2024 | AMC | 0.37 | 0.39 | +5.4% | 13.14 | -2.4% | -3.6% | -0.6% | +2.7% | -0.3% | +0.7% | — |
| Nov 14, 2023 | AMC | 0.46 | 0.43 | -6.5% | 8.80 | +0.8% | +3.5% | -5.2% | +8.0% | +1.4% | +2.0% | — |
| Aug 3, 2023 | AMC | 0.49 | 0.49 | +0.0% | 11.74 | +1.4% | -3.2% | +7.1% | -4.3% | -3.3% | -2.8% | — |
| May 4, 2023 | AMC | 0.37 | 0.41 | +10.8% | 12.05 | +0.6% | -3.2% | -3.5% | +0.1% | -2.4% | +1.1% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 10 | Canaccord Genuity | Maintains | Buy → Buy | — | $17.00 | $17.12 | +0.7% | -8.2% | -2.4% | +0.1% | +7.2% | -3.7% |
| Feb 10 | Morgan Stanley | Maintains | Underweight → Underweight | — | $17.00 | $17.12 | +0.7% | -8.2% | -2.4% | +0.1% | +7.2% | -3.7% |
| Jan 21 | TD Cowen | Maintains | Buy → Buy | — | $16.05 | $17.08 | +6.4% | +0.1% | -0.1% | -3.9% | +0.2% | -1.5% |
| Jan 21 | Raymond James | Upgrade | Market Perform → Outperform | — | $16.05 | $17.08 | +6.4% | +0.1% | -0.1% | -3.9% | +0.2% | -1.5% |
| Nov 14 | Morgan Stanley | Maintains | Underweight → Underweight | — | $14.45 | $14.15 | -2.1% | -1.9% | +0.4% | +3.0% | -4.4% | +1.0% |
| Oct 28 | Jefferies | Maintains | Hold → Hold | — | $15.26 | $15.33 | +0.5% | +1.0% | -2.5% | -3.7% | +4.3% | -5.5% |
| Sep 15 | Canaccord Genuity | Maintains | Buy → Buy | — | $15.00 | $15.25 | +1.7% | +5.3% | -4.6% | +1.6% | +1.7% | -0.3% |
| Sep 4 | TD Cowen | Maintains | Buy → Buy | — | $14.12 | $14.23 | +0.8% | +0.1% | +2.7% | +1.2% | -0.3% | -0.1% |
| Aug 6 | Canaccord Genuity | Maintains | Buy → Buy | — | $11.66 | $11.72 | +0.5% | +3.3% | -2.5% | -0.5% | +1.5% | +6.1% |
| Feb 18 | DA Davidson | Maintains | Neutral → Neutral | — | $9.29 | $9.03 | -2.8% | +0.8% | +1.3% | -1.7% | -4.1% | +2.9% |
| Jan 21 | Morgan Stanley | Maintains | Underweight → Underweight | — | $11.26 | $11.03 | -2.0% | -0.1% | -1.2% | +1.6% | -2.5% | +2.5% |
| Nov 25 | TD Cowen | Upgrade | Hold → Buy | — | $12.97 | $13.69 | +5.6% | +8.6% | +0.9% | -0.6% | -1.5% | +0.0% |
| Nov 15 | TD Cowen | Maintains | Hold → Hold | — | $13.78 | $14.19 | +3.0% | -2.7% | -0.5% | -1.9% | +0.4% | -1.2% |
| Nov 15 | Raymond James | Upgrade | Underperform → Market Perform | — | $13.78 | $14.19 | +3.0% | -2.7% | -0.5% | -1.9% | +0.4% | -1.2% |
| Nov 15 | DA Davidson | Maintains | Neutral → Neutral | — | $13.78 | $14.19 | +3.0% | -2.7% | -0.5% | -1.9% | +0.4% | -1.2% |
| Nov 15 | Morgan Stanley | Maintains | Underweight → Underweight | — | $13.78 | $14.19 | +3.0% | -2.7% | -0.5% | -1.9% | +0.4% | -1.2% |
| Aug 13 | DA Davidson | Maintains | Neutral → Neutral | — | $10.62 | $10.71 | +0.8% | +5.6% | +1.2% | +11.5% | +0.0% | +2.4% |
| Jul 11 | Piper Sandler | Maintains | Overweight → Overweight | — | $9.94 | $10.12 | +1.8% | +11.3% | -1.0% | -2.1% | +8.7% | +0.5% |
| Apr 17 | TD Cowen | Maintains | Hold → Hold | — | $10.35 | $10.40 | +0.5% | -0.4% | +2.4% | +0.4% | +1.2% | +3.4% |
| Mar 19 | Piper Sandler | Maintains | Overweight → Overweight | — | $12.19 | $11.98 | -1.7% | -1.1% | +2.2% | -0.3% | -4.7% | -3.0% |
| Feb 7 | DA Davidson | Maintains | Neutral → Neutral | — | $12.93 | $12.97 | +0.3% | -0.3% | +0.7% | +0.3% | +5.8% | -6.6% |
| Nov 15 | Morgan Stanley | Maintains | Underweight → Underweight | — | $8.80 | $8.87 | +0.8% | +3.5% | -5.2% | +8.0% | +1.4% | +2.0% |
| Aug 22 | Morgan Stanley | Maintains | Underweight → Underweight | — | $10.07 | $10.00 | -0.7% | -3.1% | -1.8% | +0.0% | +1.8% | +4.3% |
| Aug 21 | Morgan Stanley | Maintains | Underweight → Underweight | — | $10.38 | $10.28 | -1.0% | -3.0% | -3.1% | -1.8% | +0.0% | +1.8% |
| Aug 16 | DA Davidson | Maintains | Neutral → Neutral | — | $10.73 | $10.60 | -1.2% | -7.5% | +2.4% | +2.2% | -3.0% | -3.1% |
| May 5 | Morgan Stanley | Maintains | Underweight → Underweight | — | $12.05 | $12.12 | +0.6% | -3.2% | -3.5% | +0.1% | -2.4% | +1.1% |
| Feb 16 | Cowen & Co. | Maintains | Market Perform → Market Perform | — | $17.42 | $17.25 | -1.0% | -1.1% | -0.6% | -6.3% | +1.6% | +0.6% |
| Feb 6 | DA Davidson | Maintains | Neutral → Neutral | — | $17.63 | $17.37 | -1.5% | -1.6% | +1.1% | -3.3% | -2.1% | -1.8% |
| Feb 3 | Morgan Stanley | Maintains | Underweight → Underweight | — | $17.97 | $17.95 | -0.1% | -1.9% | -1.6% | +1.1% | -3.3% | -2.1% |
| Dec 15 | Piper Sandler | Maintains | Overweight → Overweight | — | $12.22 | $12.33 | +0.9% | +4.2% | +0.9% | -6.1% | -3.1% | +4.1% |
| Nov 14 | DA Davidson | Maintains | Neutral → Neutral | — | $13.34 | $13.06 | -2.1% | -5.4% | -0.7% | -6.1% | +1.1% | +3.4% |
| Aug 12 | Cowen & Co. | Downgrade | Outperform → Market Perform | — | $15.21 | $14.60 | -4.0% | -0.1% | +1.3% | +1.9% | -0.1% | +2.0% |
| Aug 8 | DA Davidson | Maintains | Neutral → Neutral | — | $13.74 | $13.74 | +0.0% | +4.5% | -2.9% | +4.1% | +4.8% | -0.1% |
| Aug 8 | Morgan Stanley | Maintains | Underweight → Underweight | — | $13.74 | $13.74 | +0.0% | +4.5% | -2.9% | +4.1% | +4.8% | -0.1% |
| Jun 29 | Raymond James | Downgrade | Market Perform → Underperform | — | $12.19 | $11.56 | -5.2% | -3.4% | +1.3% | +1.8% | +8.6% | -3.0% |
| Jun 16 | Morgan Stanley | Downgrade | Equal Weight → Underweight | — | $13.46 | $12.25 | -9.0% | -12.7% | +4.2% | -0.4% | -0.5% | +0.4% |
| May 13 | DA Davidson | Maintains | Neutral → Neutral | — | $14.77 | $14.79 | +0.1% | +2.4% | -3.2% | +1.8% | -6.0% | -2.6% |
| May 5 | Oppenheimer | Downgrade | Outperform → Perform | — | $15.95 | $14.49 | -9.2% | -6.8% | +1.2% | -1.7% | -4.0% | -0.8% |
| Jan 18 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $18.13 | $17.80 | -1.8% | -1.3% | -0.1% | -5.4% | +0.4% | +10.8% |
| Nov 15 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $20.47 | $20.50 | +0.1% | -0.6% | +1.9% | -1.0% | +3.1% | -3.2% |
| Nov 4 | Oppenheimer | Maintains | Outperform → Outperform | — | $17.40 | $17.32 | -0.5% | -2.9% | +9.0% | -2.9% | +0.7% | +0.7% |
| Aug 2 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $18.92 | $18.92 | +0.0% | -1.1% | +2.2% | -4.0% | +2.2% | +0.5% |
| Jul 30 | DA Davidson | Maintains | Neutral → Neutral | — | $20.22 | $19.62 | -3.0% | -6.4% | -1.1% | +2.2% | -4.0% | +2.2% |
| Jul 14 | Raymond James | Upgrade | Underperform → Market Perform | — | $21.10 | $21.42 | +1.5% | -0.5% | +0.6% | -2.6% | -0.1% | +5.4% |
| Jun 22 | Oppenheimer | Upgrade | Perform → Outperform | — | $19.44 | $21.37 | +9.9% | +13.6% | +0.3% | +3.2% | -1.2% | -4.1% |
| Jun 22 | Cowen & Co. | Upgrade | Market Perform → Outperform | — | $19.44 | $21.37 | +9.9% | +13.6% | +0.3% | +3.2% | -1.2% | -4.1% |
| May 7 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $24.32 | $24.85 | +2.2% | +4.0% | -2.5% | -3.9% | -5.3% | +0.1% |
| Mar 11 | Oppenheimer | Downgrade | Outperform → Perform | — | $20.90 | $20.48 | -2.0% | +1.0% | +0.9% | +0.1% | -4.7% | +2.3% |
| Feb 5 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $15.67 | $15.67 | +0.0% | -6.1% | -1.6% | +7.6% | -3.2% | -1.9% |
| Jan 20 | Morgan Stanley | Upgrade | Underweight → Equal Weight | — | $13.83 | $14.36 | +3.8% | +4.1% | +0.6% | -3.4% | +6.9% | +6.0% |
No insider trades available.
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
A key executive departure at Bed Bath & Beyond and Bed Bath & Beyond's parent company effective April 28, 2026, creates leadership uncertainty that could impact operational continuity and strategic direction during a critical turnaround period.
Apr 2
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
SBH's executive departure signals potential leadership instability and operational uncertainty, which could pressure the stock until succession clarity emerges and market confidence stabilizes.
Mar 17
8-K
Sally Beauty Holdings, Inc. -- 8-K Filing
Sally Beauty Holdings reported Q1 FY2026 results for the quarter ending December 31, 2025, and will host an earnings call to discuss performance metrics with investors.
Feb 9
Data updated apr 27, 2026 12:17am
· Source: massive.com